Skip to main content

Table 1 Baseline characteristics of non-DM patients stratified according to admission glucose

From: High admission glucose levels predict worse short-term clinical outcome in non-diabetic patients with acute myocardial infraction: a retrospective observational study

 

AG ≤ 140 mg/dL

M (P25, P75)

N = 1216

140 mg/dL<AG<180 mg/dL

M (P25, P75)

N = 370

AG ≥ 180 mg/dL

M (P25, P75)

N = 112

P

Age (years)

63 (55, 76)

64 (57, 76)

66 (57, 73)

0.022

SBP (mmHg)

127 (114, 141)

124.00 (109.75, 138.00)

125.5 (110.00, 143.75)

0.008

FPG (mg/dL)

91.08 (83.16, 101.11)

101.7 (91.26, 114.71)

109.17 (92.88, 136.80)

<0.001

AG (mg/dL)

114.12 (103.36, 125.77)

153.36 (146.11, 163.8)

204.75 (190.21, 229.63)

<0.001

HbA1C(%)

5.60 (5.3, 5.8)

5.70 (5.4, 6.0)

5.80 (5.60, 6.20)

<0.001

hs-CRP (ng/ml)

6.77 (2.25, 15.26)

7.47 (2.58, 15.95)

8.93 (2.64, 21.21)

0.201

TC (mmol/L)

4.34 (3.72, 5.08)

4.39 (3.75, 4.99)

4.23 (3.58, 4.81)

0.363

LDL-C (mmol/L)

2.51 (2.02, 3.04)

2.50 (2.06, 2.97)

2.44 (1.93, 2.87)

0.250

Cr (mg/dL)

0.95 (0.84, 1.09)

1.05 (0.83, 1.08)

0.98 (0.84, 1.20)

0.228

eGFR (ml/min·1.73m2)

80.70 (64.52, 94.89)

77.26 (65.51, 93.53)

76.51 (60.17, 87.93)

0.094

log NT-proBNP

3.16 (2.68, 3.66)

3.27 (2.78, 3.80)

3.33 (2.99, 3.87)

<0.001

CK-MB ( ng/ml)

32.10 (4.5, 105.16)

59.89 ( 7.9, 165.75)

74.90 ( 17.35, 209.25)

<0.001

cTnI ( ng/ml)

3.31 (0.53, 13.23)

6.21 (0.56, 20.17)

5.95 (1.18, 33.28)

<0.001

MYO (ng/ml)

101.5 (35.6, 250.94)

150.50 (49.83, 301.36)

175.39 (82.78, 428.25)

<0.001

EF

0.61 (0.54, 0.66)

0.59 (0.51, 0.66)

0.58 (0.51, 0.64)

0.003

HS (day)

8.0 (6.0, 10.0)

8.0 (6.0, 11.0)

8.0 (6.0, 10.0)

0.149

Male

930 (76.5)

269 (72.7)

130 (76.8)

0.32

Age over 75

324 (26.6)

110 (29.7)

25 (22.3)

0.25

EF below 0.4

88 (7.2)

27 (7.3)

7 (6.2)

0.92

STEMI

585 (48.1)

229 (61.9)

75 (67.0)

<0.001

PCI

883 (72.6)

285 (77.0)

89 (79.5)

0.09

IMR

14 (1.2)

15 (4.1)

6 (5.4)

<0.001

OMI

130 (10.7)

43 (11.6)

11 (9.8)

0.82

Hypertension

7718 (59.0)

241 (65.1)

72 (64.3)

0.08

Dyslipidemia

511 (42.0)

170 (45.9)

52 (46.4)

0.32

CKD

55 (4.5)

19 (5.1)

5 (4.5)

0.88

Stroke history

167 (13.7)

65 (17.6)

14 (12.5)

0.15

Current smoking

589 (48.4)

159 (43.0)

48 (42.9)

0.12

Medication befor admission

 Aspirin

134 (11)

33 (8.9)

16 (14.3)

0.24

 CCB

325 (26.7)

115 (31.1)

37 (33.0)

0.13

 β-blocker

131 (10.8)

48 (13.0)

13 (11.6)

0.50

 ACEI

104 (8.6)

36 (9.7)

9 (8.0)

0.75

 ARB

177 (14.6)

44 (11.9)

19 (17)

0.29

 Statin

136 (11.2)

56 (15)

10 (8.9)

0.07

  1. AG Admission glucose, SBP Systolic blood pressure, FPG Fasting plasma glucose, HbA1c Glycosylated hemoglobin, hs-CRP High-sensitivity C-reactive protein, TC Total cholesterol, LDL-C Low-density lipoprotein cholesterol, Cr Creatinine, eGFR estimated glomerular filtration rate, NT-proBNP N-terminal pro-brain natriuretic peptide, CK-MB Creatine kinase-MB, cTnI Cardiac troponin I, MYO Myoglobin, EF Ejection fraction, HS Hospital stay, STEMI ST-segment elevation myocardial infraction, PCI Percutaneous coronary intervention, IMR Insufficient myocardium reperfusion, OMI Old myocardial infraction, CKD Chronic Kidney Disease, CCB Calcium channel blocker, ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker